Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies
Clinical trial NCT02913131 · TERMINATED
Trial details
- NCT number
- NCT02913131
- Sponsor
- Rahul Aggarwal
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2021-04-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.